Was receipt of any specialty alcohol treatment during the pandemic effective at reducing drinking for patients with or at risk of AUD?

Andrea H Kline-Simon, Vanessa A Palzes, Felicia W Chi, Derek D Satre, Constance Weisner, Stacy Sterling
{"title":"Was receipt of any specialty alcohol treatment during the pandemic effective at reducing drinking for patients with or at risk of AUD?","authors":"Andrea H Kline-Simon, Vanessa A Palzes, Felicia W Chi, Derek D Satre, Constance Weisner, Stacy Sterling","doi":"10.1016/j.josat.2024.209531","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic changed the way healthcare providers delivered most health services, including treatment for alcohol use disorder (AUD). Specialty alcohol treatment remained available through the pandemic, and within some systems treatment use increased likely due to telehealth availability. However, the field knows little about the relationship between the pandemic's expanded access to specialty alcohol treatment and alcohol use outcomes.</p><p><strong>Methods: </strong>The sample included 14,712 patients from Kaiser Permanente Northern California who screened positive for unhealthy alcohol use in primary care and had an AUD diagnosis or risked developing an AUD by reporting 5 or more heavy drinking days in a 3-month period between 1/1/2019 and 2/29/2020 (pre-pandemic). The study examined the receipt of any specialty alcohol treatment (including at least one outpatient, inpatient, or telehealth specialty treatment encounter, or pharmacotherapy prescription) from 3/1/2020 (pandemic start) to either the first completed follow-up alcohol screening or 6/20/2022 (study period end). The outcomes of alcohol use included changes in heavy drinking days, drinks per week, drinking days per week, and drinks per drinking day between the pre- and post-pandemic periods.</p><p><strong>Results: </strong>On average patients significantly decreased alcohol use across all four alcohol use measures examined, regardless of whether they received treatment. However, those who received any treatment compared to those who did not have greater reductions in alcohol use, with an additional decrease of -3.55 heavy drinking days (95 % CI = -5.93, -1.17), -3.80 drinks per week (95 % CI = -5.18, -2.42), -0.72 drinks per drinking day (95 % CI = -1.14, -0.30), and - 1.01 drinking days per week (95 % CI = -1.30, -0.72). Treatment effects were greatest among patients who exceeded both daily and weekly limits pre-pandemic, with an additional decrease of -10.75 heavy drinking days (95 % CI = -15.28, -6.21), -12.83 drinks per week (95 % CI = -16.31, -9.35), -1.67 drinks per drinking day (95 % CI = -2.19, -1.14), and -2.02 drinking days per week (95 % CI = -2.41, -1.63).</p><p><strong>Conclusions: </strong>On average, patients decreased alcohol use during the onset of the pandemic, however, those who had any specialty alcohol treatment had significantly greater decreases, suggesting that the hybrid in-person and telehealth treatment approach was effective during the pandemic.</p>","PeriodicalId":73960,"journal":{"name":"Journal of substance use and addiction treatment","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of substance use and addiction treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.josat.2024.209531","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The COVID-19 pandemic changed the way healthcare providers delivered most health services, including treatment for alcohol use disorder (AUD). Specialty alcohol treatment remained available through the pandemic, and within some systems treatment use increased likely due to telehealth availability. However, the field knows little about the relationship between the pandemic's expanded access to specialty alcohol treatment and alcohol use outcomes.

Methods: The sample included 14,712 patients from Kaiser Permanente Northern California who screened positive for unhealthy alcohol use in primary care and had an AUD diagnosis or risked developing an AUD by reporting 5 or more heavy drinking days in a 3-month period between 1/1/2019 and 2/29/2020 (pre-pandemic). The study examined the receipt of any specialty alcohol treatment (including at least one outpatient, inpatient, or telehealth specialty treatment encounter, or pharmacotherapy prescription) from 3/1/2020 (pandemic start) to either the first completed follow-up alcohol screening or 6/20/2022 (study period end). The outcomes of alcohol use included changes in heavy drinking days, drinks per week, drinking days per week, and drinks per drinking day between the pre- and post-pandemic periods.

Results: On average patients significantly decreased alcohol use across all four alcohol use measures examined, regardless of whether they received treatment. However, those who received any treatment compared to those who did not have greater reductions in alcohol use, with an additional decrease of -3.55 heavy drinking days (95 % CI = -5.93, -1.17), -3.80 drinks per week (95 % CI = -5.18, -2.42), -0.72 drinks per drinking day (95 % CI = -1.14, -0.30), and - 1.01 drinking days per week (95 % CI = -1.30, -0.72). Treatment effects were greatest among patients who exceeded both daily and weekly limits pre-pandemic, with an additional decrease of -10.75 heavy drinking days (95 % CI = -15.28, -6.21), -12.83 drinks per week (95 % CI = -16.31, -9.35), -1.67 drinks per drinking day (95 % CI = -2.19, -1.14), and -2.02 drinking days per week (95 % CI = -2.41, -1.63).

Conclusions: On average, patients decreased alcohol use during the onset of the pandemic, however, those who had any specialty alcohol treatment had significantly greater decreases, suggesting that the hybrid in-person and telehealth treatment approach was effective during the pandemic.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在大流行期间,接受任何特殊酒精治疗是否能有效减少 AUD 患者或有 AUD 风险的患者的饮酒量?
导言:COVID-19 大流行改变了医疗服务提供者提供大多数医疗服务的方式,包括酒精使用障碍 (AUD) 的治疗。大流行期间仍可提供专业酒精治疗,在某些系统中,可能由于远程医疗的可用性,治疗使用率有所增加。然而,该领域对大流行病扩大了专业酒精治疗的可及性与酒精使用结果之间的关系知之甚少:样本包括 14,712 名来自北加州凯泽医疗集团(Kaiser Permanente Northern California)的患者,这些患者在初级保健中被筛查出不健康饮酒,并被诊断为 AUD,或在 2019 年 1 月 1 日至 2020 年 2 月 29 日(大流行前)的 3 个月内报告有 5 天或 5 天以上大量饮酒的风险。该研究调查了自 2020 年 3 月 1 日(大流行开始)至首次完成酒精筛查随访或 2022 年 6 月 20 日(研究期结束)期间接受任何专业酒精治疗的情况(包括至少一次门诊、住院或远程医疗专业治疗或药物治疗处方)。饮酒结果包括大流行前和大流行后期间大量饮酒天数、每周饮酒天数、每周饮酒天数和每天饮酒天数的变化:无论是否接受治疗,患者在所有四项酒精使用指标上的平均饮酒量都有明显下降。然而,与未接受治疗的患者相比,接受过任何治疗的患者饮酒量减少得更多,大量饮酒天数减少了-3.55天(95 % CI = -5.93,-1.17),每周饮酒量减少了-3.80杯(95 % CI = -5.18,-2.42),每天饮酒量减少了-0.72杯(95 % CI = -1.14,-0.30),每周饮酒天数减少了-1.01天(95 % CI = -1.30,-0.72)。在大流行前每日和每周饮酒量均超标的患者中,治疗效果最好,额外减少了-10.75个大量饮酒日(95 % CI = -15.28,-6.21)、每周-12.83杯酒(95 % CI = -16.31,-9.35)、每天-1.67杯酒(95 % CI = -2.19,-1.14)和每周-2.02个饮酒日(95 % CI = -2.41,-1.63):平均而言,患者在大流行期间减少了饮酒量,然而,接受过专业酒精治疗的患者饮酒量明显减少,这表明在大流行期间,面对面和远程医疗的混合治疗方法是有效的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of substance use and addiction treatment
Journal of substance use and addiction treatment Biological Psychiatry, Neuroscience (General), Psychiatry and Mental Health, Psychology (General)
自引率
0.00%
发文量
0
期刊最新文献
Parent SMART: Effects of residential treatment and an adjunctive parenting intervention on behavioral health services utilization. “Yeah, this is not going to work for me”–The impact of federal policy restrictions on methadone continuation upon release from jail or prison A community-academic partnership to develop an implementation support package for overdose prevention in permanent supportive housing Factors affecting problem-solving court team decisions about medications for opioid use disorder Is naloxone where it needs to be? Using spatial analytics to examine equitable distribution of community-based naloxone sites
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1